A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy.

@article{Dam1989ADS,
  title={A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy.},
  author={Mogens Hansen Dam and R Ekberg and Yngve L\oyning and Olli Waltimo and Klara Jakobsen},
  journal={Epilepsy research},
  year={1989},
  volume={3 1},
  pages={70-6}
}
Two hundred and thirty-five patients suffering from newly diagnosed epilepsy were randomly allocated to treatment with either oxcarbazepine or carbamazepine in a double-blind multi-centre study. After a titration phase (between 4 and 8 weeks), the optimal individual dose of trial medication was determined and treatment with that dose was continued for another 48 weeks. The criteria for assessment were: efficacy--seizure frequency, EEG tracings, global evaluation; tolerability--side effects… CONTINUE READING